NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Clearside Biomedical Inc (NASDAQ: CLSD)

 
CLSD Technical Analysis
5
As on 15th Sep 2025 CLSD STOCK Price closed @ 3.95 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 1.14 & Strong Buy for SHORT-TERM with Stoploss of 1.32 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

CLSDSTOCK Price

Open 4.04 Change Price %
High 4.43 1 Day 3.63 1134.38
Low 3.70 1 Week 3.60 1028.57
Close 3.95 1 Month 3.57 939.47
Volume 263846 1 Year 2.42 158.17
52 Week High 1.67 | 52 Week Low 0.33
 
NASDAQ USA Most Active Stocks
AMRS 0.14 100.00%
WBA 11.98 0.50%
OPEN 9.49 4.63%
BITF 2.48 11.21%
TSLA 410.04 3.56%
OPI 0.88 60.00%
NVDA 177.75 -0.04%
CHEK 2.12 182.67%
LMDX 0.02 0.00%
AKTS 0.04 0.00%
 
NASDAQ USA Top Gainers Stocks
MRIN 3450.00 383233.34%
MRIN 3450.00 383233.34%
KTRA 6.30 2763.64%
IDRA 8.64 1909.30%
BDSX 7.60 1900.00%
CLSD 3.95 1134.38%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
NDRAW 0.03 200.00%
CHEK 2.12 182.67%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
OTRK 0.07 -78.79%
ACAQ-UN 2.50 -73.49%
AGBA 0.35 -71.31%
AXAS 0.03 -70.00%
AXDX 0.03 -66.67%
HPKEW 0.05 -64.29%
TFFP 0.06 -62.50%
MILEW 0.06 -53.85%
 
 
CLSD
Daily Charts
CLSD
Intraday Charts
Whats New @
Bazaartrend
CLSD
Free Analysis
 
CLSD Important Levels Intraday
RESISTANCE5.36
RESISTANCE4.91
RESISTANCE4.63
RESISTANCE4.35
SUPPORT3.55
SUPPORT3.27
SUPPORT2.99
SUPPORT2.54
 
CLSD Forecast September 2025
4th UP Forecast4.55
3rd UP Forecast4.36
2nd UP Forecast4.24
1st UP Forecast4.12
1st DOWN Forecast3.78
2nd DOWN Forecast3.66
3rd DOWN Forecast3.54
4th DOWN Forecast3.35
 
CLSD Weekly Forecast
4th UP Forecast4.78
3rd UP Forecast4.51
2nd UP Forecast4.35
1st UP Forecast4.18
1st DOWN Forecast3.72
2nd DOWN Forecast3.55
3rd DOWN Forecast3.39
4th DOWN Forecast3.12
 
CLSD Forecast2025
4th UP Forecast11.93
3rd UP Forecast9.37
2nd UP Forecast7.79
1st UP Forecast6.21
1st DOWN Forecast1.69
2nd DOWN Forecast0.11
3rd DOWN Forecast-1.47
4th DOWN Forecast-4.03
 
 
CLSD Other Details
Segment EQ
Market Capital 320595040.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
CLSD Address
CLSD
 
CLSD Latest News
 
Your Comments and Response on Clearside Biomedical Inc
 
CLSD Business Profile
Clearside Biomedical, Inc., a biopharmaceutical company, engages in the developing and delivering treatments that restore and preserve vision for people with serious eye diseases. Its product includes CLS-AX, an axitinib for suprachoroidal injection which is in Phase 1/2a clinical trial. It also develops XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of macular edema associated with uveitis, diabetic macular edema, and macular edema associated with retinal vein occlusion. The company was incorporated in 2011 and is headquartered in Alpharetta, Georgia. Address: 900 North Point Parkway, Alpharetta, GA, United States, 30005
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service